Back to State Street Corp. State Street Corp.

RNAC

Showing 8 of 9 quarters

Position history for State Street Corp.State Street Corp.'s holdings in Cartesian Therapeutics, Inc.

Yes. State Street holds 249,212 shares of RNAC (Cartesian Therapeutics), worth $2.6M, as of its Q2 2026 13F filing. It increased the position by 48,875 shares (+24.4%) from Q1 2026. State Street has held RNAC in every 13F on record since Q2 2024, 9 quarterly filings.

Current Value

$2.6M

Current Shares

249,212

Total Value Change

+$57,970

Total Shares Change

+91,717

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
249,212
+24.4%
$2.6M0.0%$10.42
32
2026-Q1
Increased
200,337
+0.7%
$1.2M0.0%$6.15
17
2025-Q4
Increased
198,967
+0.7%
$1.4M0.0%$7.21
17
2025-Q3
Increased
197,666
+1.8%
$2M0.0%$10.22
26
2025-Q2
Decreased
194,269
-3.4%
$2M0.0%$10.39
0
2025-Q1
Increased
201,125
+16.5%
$2.7M0.0%$13.18
30
2024-Q4
Increased
172,620
+9.6%
$3.1M0.0%$17.91
29
2024-Q3
Increased
157,495
+2.5%
$2.5M0.0%$17.00
27

Other major holders of RNAC: FMR LLC, Squarepoint Ops LLC

Optional analytics helps us improve. How it’s used